For more information, please visit lek.com/covid19 or fill out this form to get in touch. Other editions in this series: European Disease progression monitor: Edition 4 Related Practice Life Sciences & Pharma Each week we will update our staff and clients with metrics to track disease progression 01262022170139
For more information, please visit lek.com/covid19 or fill out this form to get in touch. Other editions in this series: European Disease progression monitor: Edition 4
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Special Report Medical Equipment Collaborating for a Robust Medical Device Reimbursement Pathway in India April 2, 2024
Executive Insights Life Sciences & Pharma Research Tools and Diagnostics: Outlook and Industry Trends in 2024 March 14, 2024
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024